-transparent.png){kind=logo}
Methylxanthine consumption is associated with the development of fibrocystic disease of the breast. Methylxanthine abstention is associated with resolution of signs and symptoms of fibrocystic disease. Abstinence from methylxanthine consumption decreased breast biopsies and the need for major breast surgery because of benign disease. Methylxanthine consumption is associated with elevated cyclic adenosine monophosphate (AMP) and cyclic guanosine monophosphate (GMP) values in fibrocystic dsiease over those obtained in normal breast tissue.
Related Publications
J P Minton, and
M K Foecking, and
D J Webster, and
R H Matthews
April 1989,
Current opinion in cell biology,
J P Minton, and
M K Foecking, and
D J Webster, and
R H Matthews
March 1981,
The American journal of clinical nutrition,
J P Minton, and
M K Foecking, and
D J Webster, and
R H Matthews
January 1987,
Voprosy onkologii,
J P Minton, and
M K Foecking, and
D J Webster, and
R H Matthews
January 1984,
Advances in cyclic nucleotide and protein phosphorylation research,
J P Minton, and
M K Foecking, and
D J Webster, and
R H Matthews
October 1980,
Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology,
J P Minton, and
M K Foecking, and
D J Webster, and
R H Matthews
November 1985,
JAMA,
J P Minton, and
M K Foecking, and
D J Webster, and
R H Matthews
March 1986,
JAMA,
J P Minton, and
M K Foecking, and
D J Webster, and
R H Matthews
January 1986,
Neurology,
J P Minton, and
M K Foecking, and
D J Webster, and
R H Matthews
September 2004,
Phytochemistry,
J P Minton, and
M K Foecking, and
D J Webster, and
R H Matthews
January 1976,
Arkhiv patologii,
